Avitar, Inc. Share Price

Equities

AVTI

US0538013048

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets 17:15:51 18/04/2024 BST 5-day change 1st Jan Change
0.000014 USD +1,300.00% Intraday chart for Avitar, Inc. 0.00% 0.00%
Sales 2006 4.92M 394M Sales 2007 3.11M 249M Capitalization 178K 14.24M
Net income 2006 -3M -240M Net income 2007 -2M -160M EV / Sales 2006 0.76 x
Net Debt 2006 3.51M 281M Net Debt 2007 5.17M 414M EV / Sales 2007 1.72 x
P/E ratio 2006
-0.05 x
P/E ratio 2007
-0.04 x
Employees 36
Yield 2006 *
-
Yield 2007
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
3 years
0.00
Extreme 0
0.00
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 14/08/08
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, April 18, 2024 at 05:15 pm

More quotes
Avitar, Inc. (Avitar), through its wholly owned subsidiary Avitar Technologies, Inc. (ATI), develops, manufactures, markets and sells diagnostic test products and hydrophilic polyurethane foam disposables fabricated for medical, diagnostics, dental and consumer use. During the fiscal year ended September 30, 2007 (fiscal 2007), the Company continued the development and marketing of point-of-care oral fluid drugs of abuse tests, which use the Company’s foam as the means for collecting the oral fluid sample. Avitar sells its products and services to employers, diagnostic test distributors, medical supply companies, governmental agencies and corporations. Through its wholly owned subsidiary, BJR Security, Inc. (BJR), the Company provided, until April 30, 2007, specialized contraband detection and education services.
More about the company